In brief, treatment of eEF2K inhibitors could decrease eEF2 phosphorylation, boost de novo protein synthesis, reverse synaptic impairments, and rescue cognitive deficits in Ts65Dn DS model mice. Here, EEF2K is linked to Dravet syndrome.